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Abstract
Background:  The NeuroTrax Mindstreams  computerized cognitive assessment system was
designed for widespread clinical and research use in detecting mild cognitive impairment (MCI).
However, the capability of Mindstreams tests to discriminate elderly with MCI from those who are
cognitively healthy has yet to be evaluated. Moreover, the comparability between these tests and
traditional neuropsychological tests in detecting MCI has not been examined.
Methods: A 2-center study was designed to assess discriminant validity of tests in the Mindstreams
Mild Impairment Battery. Participants were 30 individuals diagnosed with MCI, 29 with mild
Alzheimer's disease (AD), and 39 healthy elderly. Testing was with the Mindstreams battery and
traditional neuropsychological tests. Receiver operating characteristic (ROC) analysis was used to
examine the ability of Mindstreams and traditional measures to discriminate those with MCI from
cognitively healthy elderly. Between-group comparisons were made (Mann-Whitney U test)
between MCI and healthy elderly and between MCI and mild AD groups.
Results:  Mindstreams  outcome parameters across multiple cognitive domains significantly
discriminated among MCI and healthy elderly with considerable effect sizes (p < 0.05). Measures of
memory, executive function, visual spatial skills, and verbal fluency discriminated best, and
discriminability was at least comparable to that of traditional neuropsychological tests in these
domains.
Conclusions: Mindstreams tests are effective in detecting MCI, providing a comprehensive profile
of cognitive function. Further, the enhanced precision and ease of use of these computerized tests
make the NeuroTrax system a valuable clinical tool in the identification of elderly at high risk for
dementia.
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Background
Mild cognitive impairment (MCI) is the term applied to a
condition in which elderly individuals who have a subjec-
tive cognitive complaint have objective memory impair-
ment in the absence of functional disability [1–3]. Its
importance arises from the observation that it often con-
stitutes the clinical state between normal cognition and
dementia in the elderly [4]. Approximately 12–15% of
MCI subjects per year convert to clinical dementia with
functional disability [4,5]. For this reason, much interest
has centered on the development of standardized tech-
niques for quantification of cognitive deficits in MCI and
potential therapeutic interventions for treatment of these
high-risk individuals [6].
While memory impairment is the hallmark of MCI [3],
multiple cognitive domains are compromised in the
majority of MCI individuals [7–9], as in those with mild
Alzheimer's disease (AD). Therefore, sufficiently broad
and sensitive instruments are key in the effective diagnosis
of these two groups. While traditional neuropsychological
tests have been shown to discriminate among individuals
with MCI and cognitively healthy elderly [10–12], there is
no standard, comprehensive neuropsychological battery
that is suitable for the screening and follow-up of mild
impairments in routine clinical care. Moreover, while
paper-based neuropsychological batteries have been
applied in research settings, they are generally impractical
for widespread clinical use due to high cost and extended
administration time.
Computerized cognitive testing has the potential to effec-
tively address the limitations posed by traditional paper-
based measures. Technical innovations for accurate meas-
urement of reaction time as well as frequency of errors
enhance overall sensitivity, and on-line adjustment of
level of difficulty may minimize ceiling or floor effects.
Standardized batteries with alternate forms allow for accu-
rate follow-up of patients over time. A computerized test-
ing session can be of shorter duration and is less expensive
than a paper-based session. Further, computerized testing
can be made widely available via the Internet and easily
administered so that high quality testing is on hand to
supplement clinical evaluation in routine patient care set-
tings. Indeed computerized tests have been developed to
assist researchers and psychologists in screening for cogni-
tive dysfunction [13,14]. We chose to evaluate Mind-
streams™ (NeuroTrax Corp, NY), a new commercially
available computerized testing system for comprehensive
clinical assessment of cognitive impairment, designed pri-
marily for use in the elderly. Specifically, we examine the
ability of Mindstreams  tests to discriminate individuals
with MCI from among cognitively healthy elderly. The
present study is the first to assess discriminant validity of
the computerized tests as compared with that of tradi-
tional neuropsychological tests.
Methods
Participants
Participants were 98 elderly individuals assessed at two
tertiary care memory clinics (Bloomfield Centre for
Research in Aging, McGill-Jewish General Hospital, Mon-
treal, Canada; Memory Disorders Clinic, Shaare Zedek
Medical Center, Jerusalem, Israel). Participants were diag-
nosed by consensus of evaluation teams led by dementia
experts at each of the sites and were diagnosed with mild
cognitive impairment (MCI), mild Alzheimer's disease
(AD), or as cognitively healthy. Diagnosis of MCI fol-
lowed Petersen et al. [15] and included the following fea-
tures: (1) a complaint of defective memory; (2) normal
activities of daily living; (3) a memory deficit documented
on mental status evaluation and supported by abnormal-
ities on neuropsychological testing; and (4) absence of
dementia. These criteria define the subtype of MCI known
as 'MCI-amnestic' [3]. Diagnosis of mild AD was accord-
ing to the Diagnostic and Statistical Manual, 4th ed. (DSM
IV). Healthy elderly had no cognitive complaints and
were volunteers for research testing. Each diagnostic
group was taken to be representative of a distinct popula-
tion defined by the criteria outlined above. Ethics Com-
mittee approval in compliance with the Declaration of
Helsinki was obtained at both testing sites, and informed
consent was obtained from all participants.
Table 1: Demographic and clinical characteristics for each of the three diagnostic groups.
Characteristic Healthy Elderly N = 39 MCI N = 30 Mild AD N = 29
Age, mean years (SD) 73.41 (8.00) 77.15 (6.43) 80.55 (4.91)
Education, mean years (SD) 14.95 (3.50) 13.07 (2.86) 11.31 (2.85)
Gender, N female 26 13 16
Computer Experience, N no 10 24 28
Handedness, N left-handed 0 1 2
MMSE, mean score (SD) 29.03 (1.11) 27.63 (1.54) 24.17 (3.25)
ADAS-cog, mean score (SD) 8.01 (3.58) 14.06 (5.23) 23.51 (8.33)
SD: standard deviationBMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
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Participants were excluded if there was a prior history of
major psychiatric disorder, major depression, or any neu-
rological disorder. All participants were native English
speakers. Demographic and clinical characteristics for
each diagnostic group are presented in Table 1. The MCI
group was older (t67 = 2.091, p = 0.040) and had fewer
years of education (t67 = 2.391, p = 0.020) relative to the
healthy elderly group. Conversely, the MCI group was
younger (t57 = 2.276, p = 0.027) and more highly educated
(t67 = 2.359, p = 0.022) than the mild AD group. The MCI
and healthy elderly groups were comparable in terms of
gender and handedness (gender: χ2[1, N = 69] = 3.757, p
= 0.053; handedness: χ2[1, N = 69] = 1.319, p = 0.251) as
were the MCI and mild AD groups (gender: χ2[1, N = 59]
= 0.827, p = 0.363; handedness: χ2[1, N = 59] = 0.388, p =
0.533). Fewer MCI participants had prior computer expe-
rience relative to the healthy elderly group (χ2 [1, N = 69]
= 20.046, p = 0.000), but more participants with MCI had
computer experience relative to those with mild AD (χ2[1,
N  = 59] = 3.863, p  = 0.049). Between-site differences
across diagnostic groups were found for years of educa-
tion (t96 = 4.315, p = 0.000), gender (χ2[1, N = 98] =
7.936, p = 0.005), and computer experience (χ2[1, N = 98]
= 12.001, p = 0.001), but not for age (t96 = 0.250, p =
0.802) or handedness (χ2[1, N = 98] = 0.140, p = 0.709).
Consistent with the expert consensus diagnoses, MCI par-
ticipants performed more poorly than healthy elderly on
the Mini-Mental State Examination (MMSE [16]; U = 279,
p = 0.000) and on the Alzheimer's Disease Assessment
Scale, cognitive subscale (ADAS-cog [17]; U = 190.500, p
= 0.000), but the MCI group performed better than the
mild AD group on these measures (MMSE: U = 570.500,
p = 0.000; ADAS-cog: U = 588.000, p = 0.000).
Procedure
All participants were administered the MMSE and the
ADAS-cog and completed the Mindstreams™ (NeuroTrax
Corp., NY) battery designed to detect mild cognitive
impairment (the "Mild Impairment Battery"). Partici-
pants at the McGill-Jewish General Hospital site (20 with
MCI, 15 healthy elderly, and 19 with mild AD) underwent
a neuropsychological battery in addition, comprising
standardized tests of memory, executive function, visual
spatial skills, and verbal fluency. Memory tests included
the Logical Memory subtest of the Wechsler Memory
Scale, 3rd Edition (WMS-III) and the Rey Auditory Verbal
Learning Test (RAVLT), Version 1. Tests of executive func-
tion included the Clock Drawing Test, the Trail Making
Test (Part A), the Digit Symbol subtest of the Wechsler
Adult Intelligence Scale, 3rd edition (WAIS-III), and the
Mental Control subtest of the WMS-III. Visual spatial
skills were assessed with the Block Design subtest of the
WAIS-III. Tests of verbal fluency included the Boston
Naming test, the Controlled Oral Word Association
(COWA) test, and the Similarities subscale of the WAIS-
III. Paper-based tests at both sites and Mindstreams tests at
the Shaare Zedek site and were administered by research
assistants blind to diagnosis. Mindstreams  tests at the
McGill-Jewish General Hospital site were administered by
a research assistant aware of the diagnoses, but unin-
volved in their determination. Notably, research assistants
at both sites were trained not to assist participants during
actual testing, but rather to ensure that they sufficiently
understood the instructions prior to each Mindstreams
test. Paper-based tests were administered first, followed by
the  Mindstreams  Mild Impairment Battery. Both Mind-
streams  and paper-based tests were administered in
English.
Mindstreams Computerized Cognitive Testing
A detailed treatment of the NeuroTrax system, including
the computerized tests, data processing, and usability con-
siderations appears in a supplementary document (Addi-
tional File 1). In brief, Mindstreams  consists of custom
software that resides on the local testing computer and
serves as a platform for interactive cognitive tests that pro-
duce precise accuracy and reaction time (millisecond
timescale) data. Tests are adaptive, in that the level of dif-
ficulty is adjusted accordingly depending upon perform-
ance. This feature increases sensitivity and minimizes the
prevalence of ceiling effects. Feedback is provided in the
practice sessions that precede each test, but not during the
actual tests. Web-based administrative features allow for
secure entry and storage of patient demographic data.
Once tests are run on the local computer, data are auto-
matically uploaded to a central sever, where calculation of
outcome parameters from raw single-trial data and report
generation occur.
The  Mindstreams  Mild Impairment Battery (administra-
tion time: 45 minutes) samples a wide range of cognitive
domains, including memory (verbal and non-verbal),
executive function, visual spatial skills, verbal fluency,
attention, information processing, and motor skills (see
Table 2). The tests that comprise this battery were
designed for use with the elderly. All responses were made
with the mouse or with the number pad on the keyboard
(intuitively similar to the telephone keypad). Participants
were familiarized with these input devices at the begin-
ning of the battery, and practice sessions prior to the indi-
vidual tests prepared them for the specific types of
responses required for each test. Outcome parameters var-
ied with each test, as in Table 2. Given the speed-accuracy
tradeoff, (e.g., [18]) a performance index (computed as
[accuracy/reaction time]*100) was computed for timed
Mindstreams tests in an attempt to capture performance
both in terms of accuracy and reaction time (RT). Tests
were run in the same fixed order for all participants.BMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
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Following are brief descriptions of the Mindstreams tests
included in the Mild Impairment Battery:
Verbal Memory
Ten pairs of words are presented, followed by a recogni-
tion test in which one member (the target) of a previously
presented pair appears together with a list of four candi-
dates for the other member of the pair. Participants must
indicate which word of the four alternatives was paired
with the target when presented previously. Four consecu-
tive repetitions of the recognition test are administered
during the 'learning' phase. An additional recognition test
is administered following a delay of approximately 10
minutes.
Non-Verbal Memory
Eight pictures of simple geometric objects are presented,
followed by a recognition test in which four versions of
each object are presented, each oriented in a different
direction. Participants are required to remember the ori-
entations of the originally presented objects. Four consec-
utive repetitions of the recognition test are administered
Table 2: Validity of Mindstreams tests in discriminating participants with mild cognitive impairment (MCI; N = 30) from cognitively 
healthy elderly (N = 39).
Cognitive Domain Mindstreams Test (outcome parameter) AUC SE Asymptotic 
Significance
95% CI
MEMORY Verbal Memory (accuracy, first repetition trial) 0.779 0.057 0.000 0.668–0.890
Verbal Memory (accuracy, second repetition trial) 0.838 0.05 0.000 0.741–0.936
Verbal Memory (accuracy, third repetition trial) 0.752 0.063 0.000 0.629–0.876
Verbal Memory Accuracy (accuracy, final repetition trial) 0.783 0.062 0.000 0.662–0.904
Verbal Memory (accuracy, all repetition trials) 0.859 0.048 0.000 0.765–0.953
Verbal Memory (accuracy, delayed recognition) 0.771 0.061 0.000 0.651–0.890
Non-Verbal Memory (accuracy, first repetition trial) 0.654 0.067 0.033 0.522–0.786
Non-Verbal Memory (accuracy, second repetition trial) 0.698 0.069 0.006 0.563–0.833
Non-Verbal Memory (accuracy, third repetition trial) 0.712 0.065 0.003 0.585–0.839
Non-Verbal Memory Accuracy (accuracy, final repetition trial) 0.773 0.061 0.000 0.654–0.892
Non-Verbal Memory (accuracy, all repetition trials) 0.756 0.063 0.000 0.633–0.879
Non-Verbal Memory (accuracy, delayed recognition) 0.728 0.065 0.002 0.601–0.854
EXECUTIVE 
FUNCTION
Go-NoGo (accuracy) 0.736 0.065 0.001 0.608–0.863
Go-NoGo (performance index) 0.810 0.056 0.000 0.701–0.920
Problem Solving (accuracy) 0.768 0.059 0.000 0.653–0.884
Stroop Interference (performance index) 0.703 0.077 0.023 0.551–0.854
Catch Game (accuracy) 0.696 0.075 0.016 0.548–0.843
VISUAL SPATIAL Visual Spatial Imagery (accuracy) 0.765 0.060 0.000 0.648–0.881
VERBAL Verbal Function (accuracy, naming) 0.716 0.067 0.005 0.584–0.848
Verbal Function (accuracy, rhyming) 0.824 0.051 0.000 0.724–0.923
ATTENTION Go-NoGo (RT) 0.771 0.063 0.000 0.648–0.893
Go-NoGo (standard deviation of RT) 0.706 0.066 0.006 0.576–0.835
Choice Reaction Time (performance index) 0.490 0.084 0.894 0.326–0.653
INFORMATION 
PROCESSING
Staged Information Processing, Low Load (performance 
index)
0.579 0.083 0.345 0.416–0.743
Staged Information Processing, Medium Load (performance 
index)
0.783 0.070 0.001 0.646–0.920
Staged Information Processing, High Load (performance 
index)
0.688 0.088 0.037 0.515–0.860
MOTOR SKILLS Finger Tapping (inter-tap interval) 0.595 0.076 0.215 0.446–0.744
Finger Tapping (standard deviation of inter-tap interval) 0.625 0.080 0.101 0.469–0.782
Catch Game (time to first move) 0.521 0.082 0.797 0.360–0.682
Mindstreams outcome parameters with insufficient data (<13 data points per group) due to failed practice sessions (see Methods) were excluded. 
AUC = area under the curve SE = standard error CI = confidence interval RT = reaction timeBMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
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during the 'learning' phase of the test. An additional rec-
ognition test is administered following a delay of approx-
imately 10 minutes.
Go-NoGo test
A series of large colored stimuli are presented at pseudo-
random intervals. Participants are instructed to respond as
quickly as possible by pressing a mouse button if the color
of the stimulus is any color except red, for which no
response is to be made.
Problem Solving
Pictorial puzzles of gradually increasing difficulty are pre-
sented. Each puzzle consists of a 2 × 2 array containing
three black-and-white geometric forms with a certain spa-
tial relationship among them and a missing form. Partici-
pants must choose the best fit for the fourth (missing)
form from among six possible alternatives.
Mindstreams Stroop test
The Stroop is a well-established test of response inhibition
[19]. The Mindstreams Stroop test consists of three phases.
Participants are presented with a pair of large colored
squares, one on the left and the other on the right side of
the screen. In each phase, participants are instructed to
choose as quickly as possible which of the two squares is
a particular color by pressing either the left or right mouse
button, depending upon which of the two squares is the
correct color. First, participants are presented with a gen-
eral word in colored letters. In the next phase (termed the
Choice Reaction Time test), participants are presented
with a word that names a color in white letters. In the final
phase (the Stroop phase), participants are presented with
a word that names a color, but the letters of the word are
in a color other than that named by the word. The instruc-
tions for the final phase are to choose the color of the let-
ters, and not the color named by the word.
Verbal Function
Pictures of common objects of low and high familiarity
are presented. Participants are instructed to select the
name of the picture from four choices. In a related test,
participants are instructed to select the word that best
rhymes with the name of the picture.
Visual Spatial Imagery
Computer-generated scenes containing a red pillar are
presented. Participants are instructed to imagine viewing
the scene from the vantage point of the red pillar. Four
alternative views of the scene are presented as choices.
Staged Information Processing test
This test comprises three levels of information processing
load: single digits, two-digit arithmetic problems (e.g., 5-
1), and three-digit arithmetic problems (e.g., 3+2-1). For
each of the three levels, stimuli are presented at three dif-
ferent fixed rates, incrementally increasing as testing con-
tinues. Participants are instructed to respond as quickly as
possible by pressing the left mouse button if the digit or
result is less than or equal to 4 and the right mouse button
if it is greater than 4.
Finger Tapping
Participants are instructed to tap on the mouse button for
12 seconds with their dominant hand. This task is
repeated twice.
Catch Game
The Catch game is a novel motor screen that assesses cog-
nitive domains distinct from those in other Mindstreams
tests. Participants must "catch" a rectangular white object
falling vertically from the top of the screen before it
reaches the bottom of the screen. Mouse button presses
move a rectangular green "paddle" horizontally so that it
can be positioned directly in the path of the falling object.
The test requires hand-eye coordination, scanning and
rapid responses.
Data Analysis
Mindstreams data were uploaded to the NeuroTrax central
server, where automatic data processing occurred, during
which aggregate outcome parameters were computed
from the raw single-trial data (Additional File 1). Out-
come parameters were calculated using custom software
that was blind to diagnosis or testing site, and results were
relayed to each of the sites for review and analysis. Out-
come parameters were computed for each test only when
performance on the preceding practice session exceeded a
predetermined minimum accuracy. The actual test was
not given when practice session performance was below
this cutpoint. Given this source of 'missing' data, a mini-
mum of 13 data points was deemed acceptable for inclu-
sion of a group in statistical analyses.
All statistics were computed with SPSS statistical software
(SPSS, Chicago, IL). Two-tailed statistics were used
throughout, and p  < 0.05 was considered significant.
Receiver operating characteristic (ROC) analysis was used
to evaluate the ability of Mindstreams outcome parameters
and traditional neuropsychological tests to discriminate
participants with MCI from cognitively healthy elderly.
Area under the curve (AUC), an index of effect size, was
the primary result of the ROC analysis. For each measure,
the AUC indicated the probability that a randomly
selected individual with MCI would perform more poorly
than a randomly selected cognitively healthy individual.
An AUC of 0.50 indicated no better than chance discrim-
inability, and an AUC of 1.00 indicated perfect discrimi-
nability. If the 95% confidence interval around an AUC
included 0.50, the measure was unable to discriminateBMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
Page 6 of 12
(page number not for citation purposes)
among MCI and healthy elderly at a significance level of p
< 0.05. Separate between-group comparisons were made
on Mindstreams outcome parameters between MCI and
cognitively healthy and between MCI and mild AD. Given
heterogeneous variances across these pairs of groups for
numerous outcome parameters (Brown-Forsythe test, p >
0.05), the non-parametric Mann-Whitney U was used to
make the comparisons.
Results
Discriminant Validity of Mindstreams Outcome 
Parameters: Effect Sizes
Results of an ROC analysis measuring the ability of Mind-
streams  outcome parameters to discriminate MCI from
cognitively healthy elderly are presented in Table 2, subdi-
vided by cognitive domain. All Mindstreams memory out-
come parameters discriminated significantly, with a
maximum AUC of 0.859 for mean accuracy across all rec-
ognition test repetitions in the 'learning' phase of the Ver-
bal Memory test. Similarly, all executive function
outcome parameters discriminated significantly, with a
maximum AUC of 0.810 for the Go-NoGo performance
index. All outcome parameters measuring visual spatial
skills and verbal fluency discriminated significantly, with
a maximum AUC of 0.824 for accuracy on the rhyming
portion of the Verbal Function test. Significant discrimi-
nability was found for attention outcome parameters
from the Go-NoGo test, with an AUC of 0.771 for Go-
NoGo RT and 0.706 for Go-NoGo standard deviation of
RT. The Choice Reaction Time performance index did not
discriminate significantly among MCI and cognitively
healthy elderly. Medium- (AUC = 0.783) and high-load
(AUC = 0.688) information processing outcome parame-
ters discriminated significantly, but the low-load parame-
ter did not. All motor skills outcome parameters did not
discriminate significantly.
Effect Sizes of Mindstreams Outcome Parameters Relative to 
Traditional Neuropsychological Tests
Table 3 presents ROC analysis results for the subset of
MCI and healthy elderly participants who received a bat-
tery of standardized neuropsychological tests in addition
to Mindstreams  testing. For each cognitive domain, the
ability of Mindstreams outcome parameters to discrimi-
nate MCI from cognitively healthy elderly was compared
with paper-based neuropsychological tests designed to
tap the same domain. Outcome parameters measuring
attention, information processing, and motor skills were
excluded from this analysis for lack of corresponding tra-
ditional tests in these cognitive domains.
As above (Table 2), the Mindstreams  memory outcome
parameter that best discriminated MCI from cognitively
healthy elderly was accuracy across the 'learning' phase of
the Verbal Memory test (AUC = 0.894; Table 3); the best
traditional memory test was the WMS-III Logical Memory
II subtest (AUC = 0.885). Also as above, the Mindstreams
executive function outcome parameter that discriminated
best was the Go-NoGo performance index (AUC = 0.840);
the best traditional executive function test was the WAIS-
III Digit Symbol subtest (AUC = 0.729; Figure 1A). The
Mindstreams visual spatial outcome parameter discrimi-
nated significantly (AUC = 0.778), but the corresponding
WAIS-III Block Design subtest did not (Figure 1B). The
Mindstreams verbal outcome parameter that discriminated
best was accuracy on the naming portion of the Verbal
Function test (AUC = 0.837); the best traditional verbal
test was the COWA FS test (AUC = 0.768).
Discriminant Validity of Mindstreams Outcome 
Parameters: Group Differences
Mindstreams outcome parameters discriminated MCI from
cognitively healthy and from mild AD (e.g., Figure 2).
Descriptive statistics for outcome parameters in each cog-
nitive domain are presented in Table 4, subdivided by
diagnostic group. The results of two Mann-Whitney U
tests are shown for each parameter, one comparing MCI
and healthy elderly participants and the other comparing
MCI and mild AD participants. Results for the MCI/
healthy elderly comparison are similar to those in Table 2.
For cognitive domains with sufficient data for conclusive
results, significant differences between MCI and mild AD
participants were found for memory, visual spatial, and
verbal outcome parameters. Results were mixed for atten-
tion outcome parameters, such that timed Go-NoGo
parameters did not significantly discriminate among MCI
and mild AD, but the performance index from the Choice
Reaction Time test did.
Discussion
Cognitive assessment is essential to the effective care and
treatment of the elderly. Given that the number of elderly
is predicted to increase steeply as the baby boomer gener-
ation ages [20], there is an urgent need for standardized
cognitive assessment tools that deliver high quality infor-
mation and are practical for routine clinical use. Tradi-
tional paper-based neuropsychological testing is seriously
limited by the formidable cost in time and money. We
therefore evaluated a novel computerized cognitive test-
ing system, the Mindstreams  system (NeuroTrax Corp.,
NY), which was designed for widespread clinical applica-
tion in the detection of MCI and mild dementia.
The present study evaluated the discriminant validity of
Mindstreams tests in distinguishing individuals with MCI
from healthy elderly. Outcome parameters across multi-
ple cognitive domains significantly discriminated among
MCI and healthy elderly with considerable effect sizes
(Table 2). Particularly strong results were obtained for
outcome parameters assessing memory, executiveBMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
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Discriminant Validity of Executive Function and Visual Spatial Tests Figure 1
Discriminant Validity of Executive Function and Visual Spatial Tests. Receiver operating characteristic (ROC) curves demon-
strating the ability of Mindstreams tests to discriminate individuals with mild cognitive impairment (MCI) from among cognitively 
healthy elderly as compared to traditional neuropsychological tests (MCI: N = 20; Healthy Elderly: N = 15). In (A), discrimina-
bility of the Mindstreams Go-NoGo performance index is compared with that of the Wechsler Adult Intelligence Scale, 3rd Edi-
tion (WAIS-III) Digit Symbol subtest. In (B), discriminability of accuracy on the Mindstreams Visual Spatial Imagery test is 
compared with that of the WAIS-III Block Design subtest. Discriminant validity of the Mindstreams tests was better than tradi-
tional paper-based tests designed to tap similar cognitive domains. AUC=area under the curve.
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function, visual spatial skills, and verbal function. Further,
effect sizes of the computerized tests in these domains
were at least comparable to neuropsychological tests
designed to assess the same domains (Table 3; Figure 1).
Results were mixed for Mindstreams attention and infor-
mation processing outcome parameters, and those assess-
ing motor skills did not discriminate among MCI and
healthy elderly (Table 2).
The current findings are consistent with those of studies
designed to identify traditional neuropsychological tests
that predict conversion to dementia. Many such studies
have found standard tests of verbal- and non-verbal
Table 3: Validity of Mindstreams tests in discriminating mild cognitive impairment (MCI; N = 20) from cognitively healthy elderly (N = 
15) as compared with traditional paper-based tests of the same cognitive domains.
Cognitive 
Domain
Mindstreams Test (outcome 
parameter)
AUC SE Asymptotic 
Significance
95% CI Traditional 
Measure
AUC SE Asymptotic 
Significance
95% CI
MEMORY Verbal Memory (accuracy, first 
repetition trial)
0.848 0.066 0.001 0.719–0.977 WMS-III 
Logical 
Memory I
0.800 0.076 0.003 0.650–0.950
Verbal Memory (accuracy, 
second repetition trial)
0.831 0.071 0.001 0.692–0.971 WMS-III 
Logical 
Memory II
0.885 0.055 0.000 0.778–0.992
Verbal Memory (accuracy, third 
repetition trial)
0.720 0.089 0.031 0.547–0.894 RAVLT 
Immediate 
Recall A
0.632 0.096 0.188 0.443–0.820
Verbal Memory Accuracy 
(accuracy, final repetition trial)
0.752 0.086 0.014 0.583–0.920 RAVLT 
Total
0.833 0.068 0.001 0.701–0.966
Verbal Memory (accuracy, all 
repetition trials)
0.894 0.056 0.000 0.785–1.000 RAVLT 
Immediate 
Recall B
0.688 0.091 0.06 0.510–0.866
Verbal Memory (accuracy, 
delayed recognition)
0.748 0.085 0.015 0.582–0.914 RAVLT 
Short Term 
Retention
0.874 0.062 0.000 0.752–0.995
Non-Verbal Memory (accuracy, 
first repetition trial)
0.654 0.097 0.127 0.464–0.844 RAVLT 
Delayed 
Recall
0.846 0.073 0.001 0.702–0.990
Non-Verbal Memory (accuracy, 
second repetition trial)
0.681 0.095 0.074 0.494–0.867 RAVLT 
Recognition
0.823 0.073 0.001 0.680–0.965
Non-Verbal Memory (accuracy, 
third repetition trial)
0.642 0.097 0.160 0.453–0.831
Non-Verbal Memory Accuracy 
(accuracy, final repetition trial)
0.686 0.093 0.066 0.505–0.867
Non-Verbal Memory (accuracy, 
all repetition trials)
0.719 0.090 0.030 0.542–0.897
Non-Verbal Memory (accuracy, 
delayed recognition)
0.684 0.094 0.069 0.499–0.869
EXECUTIVE 
FUNCTION
Go-NoGo (accuracy) 0.742 0.088 0.019 0.570–0.915 Clock 
Drawing
0.680 0.092 0.072 0.499–0.861
Go-NoGo (performance index) 0.840 0.069 0.001 0.705–0.976 Trail Making 
Test A
0.660 0.092 0.11 0.479–0.841
Problem Solving (accuracy) 0.685 0.098 0.077 0.492–0.877 WAIS-III 
Digit Symbol
0.729 0.091 0.03 0.550–0.908
WMS-III 
Mental 
Control
0.706 0.092 0.05 0.525–0.888
VISUAL 
SPATIAL
Visual Spatial Imagery 
(accuracy)
0.778 0.079 0.007 0.622–0.934 WAIS-III 
Block Design
0.599 0.102 0.347 0.400–0.798
VERBAL Verbal Function (accuracy, 
naming)
0.777 0.085 0.009 0.610–0.944 Boston 
Naming Test
0.747 0.082 0.014 0.585–0.908
Verbal Function (accuracy, 
rhyming)
0.837 0.070 0.001 0.700–0.973 COWA FS 0.768 0.081 0.008 0.609–0.928
COWA A 0.739 0.086 0.018 0.570–0.907
COWA 
Animals
0.711 0.088 0.037 0.538–0.883
WAIS-III 
Similarities
0.553 0.11 0.618 0.337–0.768
Mindstreams outcome parameters with insufficient data (<13 data points per group) due to failed practice sessions (see Methods) were excluded. 
AUC = area under the curve WMS-III = Wechsler Memory Scale, 3rd edition SE = standard error RAVLT = Rey Auditory Verbal Learning Test, 
Version 1 CI = confidence interval WAIS-III = Wechsler Adult Intelligence Scale, 3rd Edition RT = reaction time COWA = Controlled Oral Word 
AssociationBMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
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memory and executive function to be excellent predictors
[10,11,21–23]. Others have found verbal fluency to be a
good predictor [24,25], and a recent report by Mapstone
et al. [12] suggests that visual spatial impairment may also
predict conversion to dementia. Hence every cognitive
domain with strong discriminant validity for Mindstreams
outcome parameters in MCI has been associated with pre-
diction of conversion to dementia in studies of traditional
tests.
Computerized tests other than Mindstreams  have been
employed to discriminate MCI from cognitively healthy
elderly. Indeed the paired associates learning (PAL) test of
the Cambridge Neuropsychological Test Automated Bat-
tery (CANTAB) has been shown sensitive to cognitive
decline [26]. While demonstrating the general utility of
computerized cognitive testing, the CANTAB-PAL is lim-
ited in scope, difficult to use, and requires specialized
equipment. A brief set of three tests developed by
CogState Ltd. and administered serially four times in 3
hours has recently been shown to discriminate among
MCI and cognitively healthy elderly on the basis of learn-
ing performance [7]. However, the CogState tests fail to
provide a comprehensive cognitive profile, consisting
exclusively of reaction time tests. Finally, MicroCog [27],
a multi-domain computerized battery, showed good dis-
criminability among participants with mild dementia and
cognitively healthy elderly in an initial validity study [28].
However, MicroCog has not been widely used clinically,
likely because it tests only selected cognitive domains and
must be administered by a trained psychologist [29].
It is important to note that the results reported in the
present study are preliminary. Population based studies
with longitudinal follow-up, pathological confirmation
of diagnosis, and comparison with a wider array of tradi-
tional tests are required to fully establish the validity of
the Mindstreams tests in MCI detection. Further, given the
between-group differences in age and years of education
in the present study, future studies must collect normative
data on Mindstreams  tests so that performance can be
standardized according to age and years of education.
Given the between-group difference in computer experi-
ence in the present study, subsequent studies will collect
more detailed information on participants' facility with
the computer in general and with each of the Mindstreams
tests in particular. However, the absence of between-
group differences on Mindstreams motor skills tests in the
current study, those most dependent upon facility with
the computer, suggests that differential computer experi-
ence did not confound the results. Finally, future work
might incorporate test data in the event of a failed practice
session. As such data was labeled 'missing' in the present
study, the reported results likely underestimate the true
discriminant validity of the Mindstreams tests.
An important limitation imposed upon the present study
and all studies of MCI arises from lack of consensus
regarding the clinical definition of MCI [30,31]. Our MCI
participants were selected according to the standard defi-
nition in the field [4], but these criteria for 'MCI-amnestic'
[3] require only memory impairment. Consistent with the
present results, individuals classified as 'MCI-amnestic'
are often impaired in other cognitive domains [7–9]. A
more clinically valid classification of this pre-dementia
Discriminant Validity of Non-Verbal Memory Test Figure 2
Discriminant Validity of Non-Verbal Memory Test. During 
the 'learning phase' of the Mindstreams Non-Verbal Memory 
test, four consecutive repetitions of a recognition test were 
administered. In (A), mean accuracy is shown across repeti-
tions for cognitively healthy elderly (diamonds), mild cogni-
tive impairment (MCI; squares), and mild Alzheimer's disease 
(AD; triangles) participants. (B) depicts mean performance (+ 
standard error) for each of the diagnostic groups on the final 
repetition trial. MCI participants are discriminable from 
healthy elderly and from those with mild AD (see Table 4).
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state may be Aging-Associated Cognitive Decline (AACD;
[32]), which has clearly defined diagnostic criteria and
requires impairment in multiple cognitive domains
[30,31]. Indeed AACD has recently been validated as a
predictor of conversion to dementia [33,34].
Computerized testing has been criticized relative to paper-
based testing in terms of technical limitations and appro-
priateness for clinical use [35]. Perhaps the most pervasive
technical limitation is measurement error that varies
depending upon the refresh rate of the monitor, the sam-
pling rate of the input device, operating system activities,
and the data acquisition software. Mindstreams, which
runs under Microsoft Windows, utilizes the DirectX
library to minimize imprecision due to operating system
activities and data acquisition software to sub-millisecond
levels. The remaining sources of error are hardware-
dependent and typically result in imprecision on the order
of less then 20 milliseconds, still far better than human
measurement error. Computerized assessment has also
been criticized on the grounds that testing is not
customizable for the individual participant. While paper-
Table 4: Discriminant validity of Mindstreams computerized tests: summary statistics and group differences (Mann-Whitney U).
Cognitive 
Domain
Mindstreams Test (outcome parameter) Healthy Elderly 
N = 39
MCI N = 30 Mild AD N = 29 MCI / Healthy 
Elderly p-value
MCI / Mild AD 
p-value
MEMORY Verbal Memory (accuracy, first repetition trial) 71.35 (18.88) 48.21 (22.94) 24.00 (20.41) 0.000 0.000
Verbal Memory (accuracy, second repetition trial) 87.37 (13.09) 60.71 (25.08) 23.60 (23.96) 0.000 0.000
Verbal Memory (accuracy, third repetition trial) 94.47 (7.60) 71.43 (29.9) 20.80 (22.16) 0.000 0.000
Verbal Memory Accuracy (accuracy, final repetition trial) 97.37 (5.54) 73.21 (29.07) 22.00 (23.8) 0.000 0.000
Verbal Memory (accuracy, all repetition trials) 88.08 (8.51) 63.68 (24.13) 22.76 (21.72) 0.000 0.000
Verbal Memory (accuracy, delayed recognition) 87.30 (12.17) 62.50 (30.26) 18.40 (19.30) 0.000 0.000
Non-Verbal Memory (accuracy, first repetition trial) 49.92 (21.25) 38.71 (15.61) 27.96 (16.35) 0.027 0.017
Non-Verbal Memory (accuracy, second repetition trial) 63.11 (20.63) 46.68 (25.91) 30.13 (13.95) 0.006 0.014
Non-Verbal Memory (accuracy, third repetition trial) 74.89 (23.65) 55.18 (27.44) 30.74 (17.98) 0.003 0.002
Non-Verbal Memory Accuracy (accuracy, final repetition 
trial)
82.84 (18.19) 55.64 (28.36) 28.92 (15.33) 0.000 0.000
Non-Verbal Memory (accuracy, all repetition trials) 67.79 (17.17) 49.21 (20.36) 28.96 (11.24) 0.000 0.000
Non-Verbal Memory (accuracy, delayed recognition) 74.92 (21.92) 55.14 (25.00) 37.68 (17.65) 0.002 0.012
EXECUTIVE 
FUNCTION
Go-NoGo (accuracy) 94.28 (6.59) 84.89 (18.93) 81.90 (14.19) 0.001 0.238
Go-NoGo (performance index) 20.55 (2.63) 16.47 (3.75) 13.68 (4.77) 0.000 0.036
Problem Solving (accuracy) 73.45 (15.27) 61.36 (13.09) 55.00 (15.62) 0.000 0.161
Stroop Interference (performance index) 11.70 (6.40) 7.16 (5.38) --- 0.023 ---
Catch Game (accuracy) 59.67 (14.91) 46.24 (19.80) --- 0.016 ---
VISUAL 
SPATIAL
Visual Spatial Imagery (accuracy) 60.16 (15.61) 44.37 (15.53) 35.56 (15.43) 0.000 0.015
VERBAL Verbal Function (accuracy, naming) 92.33 (8.79) 83.22 (14.05) 66.96 (18.37) 0.004 0.002
Verbal Function (accuracy, rhyming) 80.38 (16.97) 52.21 (29.36) 37.79 (22.79) 0.000 0.02
ATTENTION Go-NoGo (RT) 464.39 (56.66) 556.04 
(102.82)
666.38 (243.81) 0.000 0.244
Go-NoGo (standard deviation of RT) 119.17 (46.40) 171.96 
(89.02)
242.81 (160.75) 0.006 0.149
Choice Reaction Time (performance index) 15.84 (3.84) 15.52 (5.51) 9.34 (4.41) 0.894 0.004
INFORMATION 
PROCESSING
Staged Information Processing, Low Load (performance 
index)
15.21 (1.91) 14.52 (2.28) --- 0.345 ---
Staged Information Processing, Medium Load 
(performance index)
8.83 (1.55) 7.04 (1.75) --- 0.001 ---
Staged Information Processing, High Load (performance 
index)
5.55 (1.16) 4.71 (1.51) --- 0.037 ---
MOTOR SKILLS Finger Tapping (inter-tap interval) 221.10 (42.71) 242.83 
(64.88)
279.00 (66.09) 0.215 0.055
Finger Tapping (standard deviation of inter-tap interval) 38.38 (28.82) 58.35 (49.46) 66.62 (78.09) 0.101 0.888
Catch Game (time to first move) 774.91 (158.10) 783.14 
(169.16)
--- 0.797 ---
Summary statistics presented as mean (standard deviation). Accuracies are given as percent correct. Timed outcome parameters are given in 
milliseconds. '---' indicates insufficient data (<13 data points per group) due to failed practice sessions (see Methods). MCI = mild cognitive 
impairment AD = Alzheimer's disease RT = reaction timeBMC Geriatrics 2003, 3 http://www.biomedcentral.com/1471-2318/3/4
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based tests are indeed more flexible, the inherent lack of
uniformity confounds the valid comparison of test results
across participants. Further, Mindstreams testing batteries
can be customized to suit specific clinical needs. Batteries
can be constructed to include only relevant tests, and
stimulus presentation parameters can be altered as appro-
priate for a particular clinical population.
We found Mindstreams tests straightforward to administer
and easy for even the mild AD participants to learn.
Administration time for the comprehensive testing battery
used in this study (45 minutes) was appropriate, and par-
ticipants were pleased with the positive feedback that the
system provided throughout the session. The automatic
uploading and scoring of the data streamlined the entire
data collection process, and, in our view, these features
may lead to widespread adoption of computerized cogni-
tive testing.
The present study is evaluative in that it serves to guide
future studies in determining the optimal set of Mind-
streams tests and outcome parameters for differentiating
among various patient groups. For example, not all infor-
mation processing outcome parameters discriminated
equally among MCI and cognitively healthy elderly (Table
2). It appears that the level of difficulty associated with the
2-digit arithmetic (i.e., medium load) portion of the
Information Processing test discriminated best, while that
associated with the single digit (i.e., low load) portion of
the test was ineffectual in discriminating. This suggests
that level of difficulty is an important consideration in
selecting the Mindstreams parameters that best discrimi-
nate among groups. Similarly, the mixed pattern of results
for attention outcome parameters (i.e., Choice Reaction
Time did not discriminate, but Go-NoGo timed outcome
parameters did discriminate; Table 2) can be accounted
for by inter-task differences in level of difficulty. These
observations may guide both clinical research on existing
Mindstreams tests and future test development.
Conclusions
The present preliminary study demonstrates the ability of
Mindstreams computerized cognitive tests to discriminate
individuals with MCI from cognitively healthy elderly.
Mindstreams measures of memory, executive function, vis-
ual spatial skills, and verbal fluency discriminated best,
and discriminability was at least comparable to that of
traditional neuropsychological tests in these domains.
Our findings and experience with the NeuroTrax system
underscore the utility of this novel clinical tool in the
diagnosis of MCI and mild dementia in circumstances
where full neuropsychological evaluation is unavailable
or impractical. Guided by the present results, further work
is necessary to examine the suitability of Mindstreams tests
for additional clinical and non-clinical validation cohorts
and for longitudinal use.
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